Number of employees: 5
Main focus areas/active in:
- Enzyme Technologies & Bioprocesses
- Platform / Conversion Technologies
- Synthetic Biology
BIOC3 is a French start-up created in Toulouse in 2016, specializing in the production of molecules with high added value, synthetic biocatalysis of organic compounds and industrial biobrics.
Which input provides your business model/core technology towards a bio-based economy?
BIOC3 has specialized in the biocatalyse synthesis of organic compounds and industrial biobricks. In collaboration with TWB (pre-industrial demonstrator under the supervision of INRAE, INSA & CNRS), we made a POC for a proprietary production plateform, patented in 2019. Our strategy is to develop a production platform at lower cost, as an alternative to fermentation and chemical synthesis.
Which market/clients do you address and which short-/long-term goals do you have?
Our targets are biotechnology companies and chemical industries encountering difficulties in their manufacturing processes, & who want to reduce their production costs, while providing them a tool that allows them to produce molecules impossible to produce until now. We could also offer our biosynthesis platform approach to institutions, universities, technology transfer offices, start-ups.
What makes your approach unique compared to other stakeholders in this field?
Current industrial production methods (chemical synthesis, microbial fermentation, and extraction from biomass) present several challenges. BioC3, uses a new proprietary biosynthesis technique capable of competing with fermentation and cell-free to produce compounds of interest.
Get in touch!
Please fill out the form below to get in touch with us.